1. FRI0482 Safety and Tolerability of MEDI-551 in Subjects with Systemic Sclerosis (SSC): Results from A Phase 1 Randomized, Placebo-Controlled Escalating Single-Dose Study. (10th June 2014) Authors: Schiopu, E.; Chatterjee, S.; Hsu, V.; Flor, A.; Pavlovic, D.; Patra, K.; Li, J.; McKeever, K.; Herbst, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0575 BIOMARKER ANALYSIS FROM THE RISE-SSC STUDY OF RIOCIGUAT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC). (2nd June 2020) Authors: Distler, O.; Kramer, F.; Höfler, J.; Ghadessi, M.; Sandner, P.; Allanore, Y.; Denton, C.; Kuwana, M.; Matucci-Cerinic, M.; Pope, J.; Atsumi, T.; Bečvář, R.; Czirják, L.; De Langhe, E.; Hachlla, E.; Ishii, T.; Ishikawa, O.; Johnson, S.; Laapas, K.; Riccieri, V. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0091 A Retrospective Look at the Recurrence of Digital Ulcers in Patients with Scleroderma after Discontinuation of Oral Treprostinil. (10th June 2014) Authors: Shah, A.A.; Schiopu, E.; Chatterjee, S.; Csuka, M.E.; Frech, T.; Goldberg, A.; Spiera, R.; Peng, S.L.; Steen, V. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0249 LONG-TERM EXTENSION RESULTS OF RISE-SSC, A RANDOMIZED TRIAL OF RIOCIGUAT IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC). (2nd June 2020) Authors: Khanna, D.; Pope, J.; Matucci-Cerinic, M.; Kuwana, M.; Denton, C.; Allanore, Y.; Wosnitza, M.; Truchetet, M. E.; Szücs, G.; Stevens, W.; Steen, V.; Stagnaro, C.; Smith, V.; Silver, R.; Schiopu, E.; Riccieri, V.; Kramer, F.; Johnson, S.; Ishikawa, O.; Ishii, T. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0433 Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease – the Lotuss Study. (9th June 2015) Authors: Khanna, D.; Albera, C.; Fischer, A.; Seibold, J.R.; Raghu, G.; Khalidi, N.; Chung, L.; Schiopu, E.; Chen, D.; Gorina, E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗